EXACT Therapeutics AS (OSL:EXTX)
0.7000
+0.2020 (40.56%)
Inactive · Last trade price on Oct 9, 2026
EXACT Therapeutics AS Revenue
EXACT Therapeutics AS had revenue of 19.00K NOK in the half year ending June 30, 2026. In the year 2025, EXACT Therapeutics AS had annual revenue of 59.00K.
Revenue
59.00K
Revenue Growth
n/a
P/S Ratio
567.75
Revenue / Employee
7.09K
Employees
11
Market Cap
44.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 4.46K | -450.06K | -99.02% |
| Dec 31, 2022 | 454.52K | 402.52K | 774.07% |
| Dec 31, 2021 | 52.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 88.25K | -5.49M | -98.42% |
| Dec 31, 2018 | 5.58M | -2.28M | -29.01% |
| Dec 31, 2017 | 7.86M | 2.78M | 54.59% |
| Dec 31, 2016 | 5.08M | 4.88M | 2,416.86% |
| Dec 31, 2012 | 202.00K | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
EXACT Therapeutics AS News
- 2 months ago - EXACT Therapeutics AS Quarterly report: H1 2026 - Filings
- 5 months ago - EXACT Therapeutics AS Transcript: Status update - Transcripts
- 5 months ago - EXACT Therapeutics AS Press release: Status update - Filings
- 5 months ago - EXACT Therapeutics AS Slides: Status update - Filings
- 7 months ago - EXACT Therapeutics AS Annual report: H2 2025 - Filings
- 9 months ago - EXACT Therapeutics AS Transcript: Investor update - Transcripts
- 9 months ago - EXACT Therapeutics AS Slides: Investor update - Filings
- 9 months ago - EXACT Therapeutics AS Slides: Company presentation - Filings